DiaMedica Therapeutics Inc. (DMAC) Return On Assets % [USD] 2019 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from 2019 to 2024.
  • DiaMedica Therapeutics Inc. Return On Assets for the quarter ending March 31, 2024 was -34.5 %, a 21.4% increase year-over-year.
  • DiaMedica Therapeutics Inc. annual Return On Assets for 2023 was -37.9 %, a 5.93% decline from 2022.
  • DiaMedica Therapeutics Inc. annual Return On Assets for 2022 was -35.8 %, a 7.64% increase from 2021.
  • DiaMedica Therapeutics Inc. annual Return On Assets for 2021 was -38.7 %, a 32% increase from 2020.
Return On Assets, Quarterly (% [USD])
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -34.5 +9.38 +21.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -37.9 -2.12 -5.93% Oct 1, 2023 Dec 31, 2023
Q3 2023 -38.9 -6.79 -21.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -40.5 -9.58 -31% Apr 1, 2023 Jun 30, 2023
Q1 2023 -43.8 -9.75 -28.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -35.8 +2.96 +7.64% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32.1 +15.2 +32.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -30.9 +23.3 +43% Apr 1, 2022 Jun 30, 2022
Q1 2022 -34.1 +22 +39.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -38.7 +18.2 +32% Oct 1, 2021 Dec 31, 2021
Q3 2021 -47.4 +15.5 +24.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -54.2 +29.4 +35.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -56 +27.1 +32.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -57 +31.1 +35.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -62.9 +7.41 +10.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -83.6 Apr 1, 2020 Jun 30, 2020
Q1 2020 -83.1 Jan 1, 2020 Mar 31, 2020
Q4 2019 -88 Oct 1, 2019 Dec 31, 2019
Q3 2019 -70.3 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.